Presentation EuroPCR 2017

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Presenter: Lucas Boersma, Martin W. Bergmann

REGISTER for free or LOG IN to view this content

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial
Coronary
CAD Pharma
Structural Heart
Aortic Valve
Presentation
EuroPCR 2017
TAVR

Up Next

More slides +

We Recommend